Article info
PDFHepatology
Original article
Poly I:C-based rHBVvac therapeutic vaccine eliminates HBV via generation of HBV-specific CD8+ effector memory T cells
- Correspondence to Dr Jian Zhang, Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, Shandong, 250012, China; zhangj65{at}sdu.edu.cn
Citation
Poly I:C-based rHBVvac therapeutic vaccine eliminates HBV via generation of HBV-specific CD8+ effector memory T cells
Publication history
- Received November 1, 2017
- Revised November 24, 2018
- Accepted December 4, 2018
- First published January 11, 2019.
Online issue publication
October 07, 2019
Article Versions
- Previous version (11 January 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.